Satomi Aoki

Satomi Aoki

Auto-generated profile, based on publicly available information

Satomi Aoki

Department of Dermatology, Keio University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
AKAkiharu Kubo
Akiharu Kubo
TSTakashi Sasaki
Takashi Sasaki
HSHisato Suzuki
Hisato Suzuki
ASAiko Shiohama
Aiko Shiohama
SASatomi Aoki
Satomi Aoki
MAMasayuki Amagai
Masayuki Amagai
Patients with disseminated superficial actinic porokeratosis (DSAP) and linear porokeratosis (LP) exhibit monoallelic germline mutations in genes encoding mevalonate pathway enzymes, such as MVD or MVK. Here, we showed that each skin lesion of DSAP exhibited an individual second hit genetic change in the wild-type allele of the corresponding gene specifically in the epidermis, indicating that a postnatal second hit triggering biallelic deficiency of the gene is required for porokeratosis to develop. Most skin lesions exhibited one of two principal second hits, either somatic homologous recombinations rendering the monoallelic mutation biallelic or C>T transition mutations in the wild-type allele. The second hits differed among DSAP lesions but were identical in those of congenital LP, suggesting that DSAP is attributable to sporadic postnatal second hits and congenital LP to a single second hit in the embryonic period. In the characteristic annular skin lesions of DSAP, the central epidermis featured mostly second hit keratinocytes, and that of the annular ring featured a mixture of such cells and naïve keratinocytes, implying that each lesion reflects the clonal expansion of single second hit keratinocytes. DSAP is therefore a benign intraepidermal neoplasia, which can be included in the genetic tumor disorders explicable by Knudson's two-hit hypothesis.

1 November 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
SASatomi Aoki
Satomi Aoki
YHYoshiko Hirata
Yoshiko Hirata
TKTomoko Kawai
Tomoko Kawai
Kazuhiko NakabayashiKazuhiko Nakabayashi
Kazuhiko Nakabayashi
KHKenichiro Hata
Kenichiro Hata
AKAkiharu Kubo
Akiharu Kubo

2 December 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
NONoriko Ono
Noriko Ono
YIYoshihiro Ito
Yoshihiro Ito
SASatomi Aoki
Satomi Aoki
ASAiko Shiohama
Aiko Shiohama
TSTakashi Sasaki
Takashi Sasaki
AKAkiharu Kubo
Akiharu Kubo
Nagashima-type palmoplantar keratosis (also referred to as SERPINB7-related palmoplantar epidermal differentiation disorder) is the most common form of palmoplantar keratoderma in East Asia. It is characterized by erythematous hyperkeratosis, palmoplantar hyperhidrosis, and a distinctive foot odor that significantly impairs QOL. In this study, we aimed to clarify the etiology of this odor by investigating the plantar microbiome and evaluating the therapeutic effects of topical benzoyl peroxide. Compared with healthy controls, individuals with Nagashima-type palmoplantar keratosis exhibited significantly higher objective odor scores; increased bacterial load, especially in the intertoe area; and reduced microbial diversity. Corynebacterium and Staphylococcus were the predominant dysbiotic flora species. The topical application of benzoyl peroxide significantly reduced foot odor and bacterial load; increased microbial diversity; and selectively decreased Corynebacterium abundance, particularly that of C tuberculostearicum. These changes correlate with the species-specific susceptibility of skin-resident bacteria to benzoyl peroxide. Our findings suggest that microbial dysbiosis, especially the overgrowth of Corynebacterium species, is central to the pathogenesis of foot odor in Nagashima-type palmoplantar keratosis. Topical benzoyl peroxide is a promising therapeutic intervention for mitigating dysbiosis and its associated foot odor. This study highlights the potential of microbiome-targeted therapies for symptom relief in inherited skin disorders such as Nagashima-type palmoplantar keratosis.

9 September 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KUKana Ueda
Kana Ueda
AYAi Yoshioka
Ai Yoshioka
HFHarumi Fujita
Harumi Fujita
SASatomi Aoki
Satomi Aoki
HSHisato Suzuki
Hisato Suzuki
AKAkiharu Kubo
Akiharu Kubo

30 April 2023 in The Journal of Dermatology
Verified
Journal Article
Closed access
SNSatoshi Nakamizo
Satoshi Nakamizo
TMTeruasa Murata
Teruasa Murata
YIYoshihiro Ishida
Yoshihiro Ishida
SASatomi Aoki
Satomi Aoki
TSTakashi Sasaki
Takashi Sasaki
KKKenji Kabashima
Kenji Kabashima